Carisk Partners, a specialty risk transfer and care coordination company, is proud to announce the launch of its enhanced ...

Cholesterol-lowering medications, like ezetimibe, may cut liver cancer risk by 31%. Discover how this breakthrough could help ...

In a comprehensive Genomic Press Interview, Dr. Carrie E. Bearden, Professor of Psychiatry and Biobehavioral Sciences and ...

Omaha Housing Authority tenants filed a class action complaint alleging that residents have been the victims of a "sustained, intense, and insidious infestation of bed bugs" for several years, ...

University of Iowa Health Care has finalized its $280 million acquisition of Mission Cancer + Blood, advancing plans to ...

Farber, Memorial Sloan Kettering, The Sidney Kimmel Comprehensive Cancer Center and the Whiting School of Engineering at ...

Dealing with persistent pain or a recent injury? Discover how Collaborative Health Partners offers comprehensive, all-in-one solutions—from diagnosis to treatme ...

Value-based care (VBC) is a long-term sophisticated approach that looks at a patient’s full history and considers future ...

An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate (MTX), according to a new study by investigators ...

This manuscript offers valuable insights by identifying two distinct liver cancer subtypes through multi-omics integration and developing a robust prognostic model, validated across various datasets, ...

Struggling with insomnia? Learn how modern treatments and lifestyle changes can help you sleep better and regain control of ...

Burton, a lawyer at Dorsey and Whitney, said some PFAS regulations would be reversed depending on the rules' economic impact on the industry.